ã¢ã¡ãªã«å½é²ç·çã®AIï¼äººå·¥ç¥è½ï¼ã®ç 究éçºãè¡ãã¸ã§ã¤ã³ãAIã»ã³ã¿ã¼ï¼Joint AI Centerï¼JAICï¼ã®å¯æé·ã®Nand Mulchandaniæ°ã¯ãåãã¦ã®æ®ºå·åAIå µå¨ã®ããã¸ã§ã¯ããç¾å¨ããã¹ã段éã«ãããã¨ãæããã«ãããJAICã¯2018å¹´ã«è¨ç«ãããã°ããã®çµç¹ãMulchandaniæ°ã¯åã®æ®ºå·åAIå µå¨ããã¸ã§ã¯ãã®å ·ä½çãªå 容ã¯å ¬éããªãã£ãããåæ°ã¯ãæ¦è¡çãªæå 端ã®AIï¼tactical edge AIï¼ãã¨è¡¨ç¾ãã人éã«å¤æã«ãã仲ä»ãå ¥ããã¨ãæããã«ããæ¦éãªãã¬ã¼ã·ã§ã³ã§ã®ããã©ã°ã·ãã製åãã«ãªãã¨èªã£ã¦ããã ãå¤ãã®AIæè¡ãæ¦éç¨ã®å µå¨ã«æè¼ããããã¨ãã¦ãããã¨ã¯äºå®ã ããã ããç¾æç¹ã§ã¯å®å ¨èªå¾åå µå¨ã¯1ã¤ããªããæã ã¯DoDD 3000.09ã«å¾ã£ã¦AIæè¡ã®éçºãè¡ã£ã¦ãããè´æ»çï¼lethalï¼ã¨è¨ããããããªãã©ã¼ãããããã¿
ç±³Microsoftã®å ±ååµæ¥è ããã«ã»ã²ã¤ãæ°ã¨ãã®å¦»ã®ã¡ãªã³ãã»ã²ã¤ãæ°ã«ããç±³æ åå£ä½ãã«ï¼ã¡ãªã³ãã»ã²ã¤ã財å£ã¯5æ4æ¥ï¼ç¾å°æéï¼ã欧å·é£åï¼EUï¼ã主å¬ããæ°åã³ããã¦ã¤ã«ã¹å¯¾çåéã¤ãã³ããCoronavirus Global Responseãã§ã1å2500ä¸ãã«ï¼ç´133ååï¼ãå¯ä»ããã¨çºè¡¨ãããããã§å財å£ã«ããæ°åã³ãã対çã¸ã®ã³ãããã¯3åãã«ä»¥ä¸ã«ãªãã¨ãã¦ããã ä»åã®å¯ä»ã®å 訳ã¯ãã²ã¤ã財å£ãè±å»çæ åå£Wellcome TrustãMastercardãå ±åã§è¡ã£ã¦ããå»è¬åéçºããã¸ã§ã¯ãCOVID-19 Therapeutics Acceleratorã«5000ä¸ãã«ãã¯ã¯ãã³ã¨äºé²æ¥ç¨®ã®ããã®ä¸çåçGAVIã¢ã©ã¤ã¢ã³ã¹ã«5000ä¸ãã«ãæ¤æ»ã·ã¹ãã ã®éçºã«é¢ããåãçµã¿ã«2500ä¸ãã«ãã¨ãªã£ã¦ããã ã¡ãªã³ãã»ã²ã¤ãæ°ã¯åæ¥å ¬éããçºè¡¨åç»ï¼è¨
ä¸çä¿å¥æ©é¢ï¼WHOï¼ã¯3æ11æ¥ï¼ç±³æ±é¨æéï¼ãæ°åã³ããã¦ã¤ã«ã¹ã®æ¡å¤§ãï½¢ãã³ãããã¯ï¼ä¸ççæµè¡ï¼ï½£ã¨è¡¨æããã ã¢ã¡ãªã«å½å ã§ããã¦ã¤ã«ã¹æ¡å¤§ã®å è¡ãã«ã¤ãã¦ãå³ããè¦æ¹ãããå ±åæ¸ãå°é家ã®çºè¨ãç¸æ¬¡ãã§ãããä¼æ¥ãå¦æ ¡ã®ééãç¶ããç¶æ³ãä¸å¤ãã¦ããã ãã©ã³ã米大統é ï¼å³ï¼ã¨æ°åã³ããã¦ã¤ã«ã¹å¯¾çãã¼ã ã®ã¡ã³ãã¼ã§ããã¢ã³ã½ãã¼ã»ãã¡ã¦ãå士ï¼å·¦ï¼ï¼2020å¹´3æ3æ¥æ®å½±ï¼ããã¡ã¦ãæ°ã¯ãã©ã³ãæ°ã®æ¥½è¦³è«ã«è¦éãé³´ããã¦ããã REUTERS/Leah Millis 3æ11æ¥ã®ãã¦å¹³åæ ªä¾¡ã®çµå¤ã¯ããã©ã³ãæ¿æ¨©ãæ°åã³ããã¦ã¤ã«ã¹æ¡å¤§ã«ãã¾ã対å¿ãã¦ããªãã¨ããæ¸å¿µããã1400ãã«ä»¥ä¸æ´è½ããã 11æ¥æã¾ã§ã¯ï½¢è½ã¡çããããã«ç¶æ³ã¯è¯ããªãï½£ã¨çºè¨ãã¦ãããã©ã³ã米大統é ã ã£ãããå¤ã«ã¯ãã¬ãæ¼èª¬ããã¢ã¡ãªã«å½å ã§ã®ææã®æ¡å¤§ãæããããã¤ã®ãªã¹ãé¤ãã¨ã¼ãããããã®æ¸¡
ãªãªã¼ã¹ãé害æ å ±ãªã©ã®ãµã¼ãã¹ã®ãç¥ãã
ææ°ã®äººæ°ã¨ã³ããªã¼ã®é ä¿¡
å¦çãå®è¡ä¸ã§ã
j次ã®ããã¯ãã¼ã¯
kåã®ããã¯ãã¼ã¯
lãã¨ã§èªã
eã³ã¡ã³ãä¸è¦§ãéã
oãã¼ã¸ãéã
{{#tags}}- {{label}}
{{/tags}}